United States · 
What does Asset Management Ventures invest in?
Asset Management Ventures invests most often at Series A and Venture (45% of the rounds on record), in sectors such as Bioimaging, Med Device and Health.
Asset Management Ventures highlights
- 01
94 rounds on record
- 02
Mostly Series A and Venture: 45% of its rounds
- 03
Sole investor in 23 rounds, median $2.7M
- 04
12 exits from the portfolio
What they do
AMV is the leading early-stage venture capital firm investing in digital healthFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Up to $2.0M as they say
- Stages
- Pre-seedSeedSeries ASeries BGrowthPre-IPO
- Sectors
- BioimagingMed DeviceHealth
- Based in
- Palo Alto, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first94 appearances
- 2025
1 round
- Jun
- 2015
5 rounds
- Jul
- Jul
- May
- Apr
- Apr
- 2014
13 rounds
- Dec
- Nov
- Sept
- Jul
- Jul
- Jul
- Jul
- Jun
- May
- May
- Mar
- Feb
- Jan
- 2013
14 rounds
- Dec
- Oct
- Oct
- Oct
- Oct
- Sept
- Sept
- Jul
- Jun
- May
- May
- May
- Apr
- Mar
- 2012
8 rounds
- Oct
- Aug
- Jul
- Jun
- Jun
- Apr
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
BSBennett S. DubinExecutive OfficeriFiling they signed
DGDavid G. FleshmanManaging Member of the General PartneriFiling they signed
LGLouis G. LangeManaging Member of the General PartneriFiling they signed
NMNemariam MesfinChief Financial OfficeriForm ADV
RTRichard T. SimoniManaging Member of the General PartneriFiling they signed
We also hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$265Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Asset Management Ventures, LLC
- SEC number
- CRD 160606
What they claim to have backed
From their own portfolio page (on their website)
28 of 49 we have independently watched raise
3T BiosciencesAaviaAmgenArterysBenefitterCarta HealthcareDecentEsperion TherapeuticsEvidation HealthFreenomeHealthTapInCarda TherapeuticsKeepSafeLarkLiquidMMightierMozioOomaOutcomes4MeProfusaRallyPointReify HealthSubjectWellTwist BioscienceUnnatural ProductsWelkinWellDocbasys1DocWayAmygdala NeurosciencesArray InsightsAudentes TherapeuticsAutonomizeBiPar SciencesBiogen IdecCV TherapeuticsEndless healthIndi MolecularKiiNuancePMC-SierraPharmacyclicsPluto HealthProperlyRapidscanSignalVineStrataviaUniKeyVirtio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed12 in all
1DocWayBought by GenoaUndisclosedNov 2015
CardioGen SciencesBought by Audentes TherapeuticsUndisclosedSept 2015
BenefitterBought by HealthMarketsUndisclosedAug 2015
Skybox ImagingBought by Google$500MJun 2014
VetCentricBought by Vets First ChoiceUndisclosedJan 2012
ProvadeBought by Pinnacle Technical ResourcesUndisclosedOct 2011
OfferIQBought by TransactisUndisclosedSept 2010
StrataviaBought by Hewlett-PackardUndisclosedAug 2010
Coapt SystemsBought by MicroAireUndisclosedAug 2010
Servo SoftwareBought by SyncloreUndisclosedJul 2010
BiPar SciencesBought by Sanofi Aventis$500MApr 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.